Dangerous rash: documentation that holds up

Most rashes are benign; a few are the visible sign of a patient who is dying. The defensible chart documents the vital signs, a full skin exam including mucosa and the pain-out-of-proportion question, and the specific can't-miss rashes that were considered and excluded.

01What's at stake

The dangerous rashes share tells: systemic toxicity, mucosal involvement, skin pain or pain out of proportion, rapid progression, and purpura. Missing them — discharging the "drug rash" that is early SJS/TEN, or the "cellulitis" that is necrotizing fasciitis — is catastrophic. The exam, not the reassurance, is what protects the patient and the chart.

02Can't-miss differential

• SJS / TEN — painful skin, mucosal involvement (eyes, mouth, genitals), positive Nikolsky sign, blistering/sloughing; usually a drug, 1–4 weeks prior.
• Meningococcemia — fever + petechiae/purpura in an ill-appearing patient; can progress to purpura fulminans and shock.
• Necrotizing fasciitis — pain out of proportion, systemic toxicity, rapid spread, bullae/crepitus; "cellulitis" that doesn't add up.
• Toxic shock syndrome — diffuse macular erythroderma, fever, hypotension, multi-organ involvement (then desquamation).
• DRESS — fever, facial edema, diffuse rash, eosinophilia, organ (liver) involvement, 2–8 weeks after a drug.
• Anaphylaxis (urticaria + systemic), Rocky Mountain spotted fever, purpura fulminans.

03Red flags — examine for them

• Fever, hypotension, ill/toxic appearance? → meningococcemia / TSS / sepsis
• Mucosal involvement, skin pain, Nikolsky/sloughing? → SJS/TEN
• Pain out of proportion, crepitus, rapidly spreading, bullae? → necrotizing fasciitis
• Petechiae/purpura (non-blanching)? → meningococcemia / vasculitis
• New drug in the last days–weeks; facial edema/eosinophilia? → SJS/TEN / DRESS

04Workup & management

• Vital signs and a full skin exam — including mucous membranes, palms/soles, and a deliberate check for non-blanching purpura, Nikolsky sign, and disproportionate pain.
• Meningococcemia: do not delay antibiotics — empiric ceftriaxone and resuscitation; droplet precautions; blood cultures/LP as able without delaying treatment.
• Necrotizing fasciitis: a surgical emergency — early surgical consult/debridement plus broad-spectrum antibiotics; imaging/the LRINEC score support but must not delay surgery when suspicion is high.
• SJS/TEN: stop the culprit drug, fluid/wound care, ophthalmology and burn-unit/dermatology involvement; estimate body-surface area (SCORTEN).
• Toxic shock: source control (remove tampon/packing), fluids, antibiotics ± clindamycin; DRESS: stop the drug, steroids and organ workup.

05What to document

06Where charts fail

• Not documenting vital signs or a mucosal exam — the SJS/TEN tell.
• Calling necrotizing fasciitis "cellulitis" and missing pain out of proportion / systemic toxicity.
• Delaying antibiotics for the febrile, purpuric, ill-appearing patient.
• Not asking about a recent new drug (SJS/TEN, DRESS).
• Generic "return if worse" instead of specific dangerous-rash return precautions.

07Sources

• Schneider JA, Cohen PR. Stevens-Johnson syndrome and toxic epidermal necrolysis: a concise review. Adv Ther. 2017;34(6):1235-1244.
• Bastuji-Garin S, Fouchard N, Bertocchi M, et al. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol. 2000;115(2):149-153.
• Stevens DL, Bisno AL, Chambers HF, et al. IDSA practice guidelines for the diagnosis and management of skin and soft tissue infections. Clin Infect Dis. 2014;59(2):e10-e52.
• Wong CH, Khin LW, Heng KS, et al. The LRINEC score for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32(7):1535-1541.

© 2026 Kim Trinh, MD. All rights reserved. Educational only — synthesized from primary literature and guidelines. Synthetic examples. Not medical advice — apply local protocol and judgment.